부산대학교 도서관

de Chaumont, F.; Icick, R.; Gorwood, P.; Granon, S.; Forget, B.; Bouarab, C.; Mattioni, J.; Bourgeron, T.; Maskos, U.; Ramoz, N.; Besson, M.

Translational Psychiatry. 15(1)

Chabert, J.; Icick, R.; Cabé, J.; Moisset, X.; Godin, O.; Gard, S.; Aouizerate, B.; Loftus, J.; Aubin, V.; Lefrere, A.; Dubertret, C.; Roux, P.; Polosan, M.; Schwitzer, T.; Etain, B.; Moirand, R.; Olié, E.; Haffen, E.; Leboyer, M.; Courtet, P.; Walter, M.; Bouaziz, N.; Yrondi, A.; Belzeaux, R.; Llorca, P.M.; Brousse, G.; Samalin, L.

Journal of Affective Disorders. 389

Brynte, C.; Schellekens, A.F.A.; Barta, C.; Begeman, A.H.A.; Crunelle, C.L.; Daigre, C.; Demetrovics, Z.; Dom, G.; Grau-López, L.; Hernandez, M.; Icick, R.; Johnson, B.; Kapitány-Fövény, M.; van Kernebeek, M.; Konstenius, M.; Levin, F.R.; Luderer, M.; Matthys, F.; Moggi, F.; Ramos-Quiroga, J.A.; Schleussner, L.; Therribout, N.; Thomas, A.; Vorspan, F.; van den Brink, W.; Franck, J.

Journal of Clinical Psychiatry, 86, 1
The journal of clinical psychiatry

Özgen, Heval; Spijkerman, Renske; Noack, Moritz; Holtmann, Martin; Schellekens, Arnt S.A.; van de Glind, Geurt; Banaschewski, Tobias; Barta, Csaba; Begeman, Alex; Casas, Miguel; Crunelle, Cleo L.; Blanco, Constanza Daigre; Dalsgaard, Søren; Demetrovics, Zsolt; den Boer, Jacomine; Dom, Geert; Eapen, Valsamma; Faraone, Stephen V.; Franck, Johan; González, Rafael A.; Grau-López, Lara; Groenman, Annabeth P.; Hemphälä, Malin; Icick, Romain; Johnson, Brian; Kaess, Michael; Kapitány-Fövény, Máté; Kasinathan, John G.; Kaye, Sharlene S.; Kiefer, Falk; Konstenius, Maija; Levin, Frances R.; Luderer, Mathias; Martinotti, Giovanni; Matthys, Frieda I.A.; Meszaros, Gergely; Moggi, Franz; Munasur-Naidoo, Ashmita P.; Post, Marianne; Rabinovitz, Sharon; Ramos-Quiroga, Antoni; Sala, Regina; Shafi, Abu; Slobodin, Ortal; Staal, Wouter G.; Thomasius, Rainer; Truter, Ilse; van Kernebeek, Michiel W.; Velez-Pastrana, Maria C.; Vollstädt-Klein, Sabine; Vorspan, Florence; Young, Jesse T.; Yule, Amy; van den Brink, Wim; Hendriks, Vincent

European Addiction Research, 2020 Jan 01. 26(4/5), 223-232.

ICASA-group; Icick, Romain; Moggi, Franz; Slobodin, Ortal; Dom, Geert; Mathys, Frieda; van den Brink, Wim; Levin, Frances R.; Blankers, Matthijs; Kaye, Sharlene; Demetrovics, Zsolt; van de Glind, Geurt; Velez-Pastrana, Maria C.; Schellekens, Arnt S.A.

European Addiction Research, 2020 Jan 01. 26(4/5), 201-210.

Christoffer Brynte; Myriam Aeschlimann; Csaba Barta; Alex Hendikus Abraham Begeman; Amanda Bäcker; Cleo Lina Crunelle; Constanza Daigre; Laura De Fuentes-Merillas; Zsolt Demetrovics; Geert Dom; Lara Grau López; Romain Icick; Brian Johnson; Peter Joostens; Máté Kapitány-Fövény; Emily Karsinti; Falk Kiefer; Maija Konstenius; Frances R. Levin; Mathias Luderer; Wiebren Markus; Frieda Matthys; Franz Moggi; Raul Felipe Palma-Alvarez; Maria Paraskevopoulou; J. Antoni Ramos-Quiroga; Arnt Schellekens; Leila M. Soravia; Norman Therribout; Anil Thomas; Geurt van de Glind; Michiel Willem van Kernebeek; Sabine Vollstädt-Klein; Florence Vorspan; Wim van den Brink; Johan Franck

BMC Psychiatry, Vol 22, Iss 1, Pp 1-8 (2022)

Brynte C; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Sweden. Electronic address: Christoffer.brynte@ki.se.; Schellekens A; Radboudumc, Donders Centre for Medical Neuroscience, Department of Psychiatry, Nijmegen, the Netherlands; Nijmegen Institute for Scientist Practitioners in Addiction (NISPA), Nijmegen, the Netherlands.; Konstenius M; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Sweden.; Begeman AHA; Outpatient Treatment Centre Amersfoort, De Hoop ggz Polikliniek Amersfoort, Amersfoort, the Netherlands; Centre for Research and Innovation in Christian Mental Health Care, Hoevelaken, the Netherlands.; Crunelle CL; Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Dpt of Psychiatry and NEUR Research Group, Center for Neurosciences (C4N), Brussels, Belgium.; Demetrovics Z; Flinders University Institute for Mental Health and Wellbeing, College of Education, Psychology and Social Work, Flinders University, Bedford Park, South Australia, Australia; Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary; Centre of Excellence in Responsible Gaming, University of Gibraltar, Gibraltar, Gibraltar.; Dom G; Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Belgium; Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Psychiatry, Laarbeeklaan 101, 1090 Brussels, Belgium.; Icick R; Université Paris-Cité, INSERM, Optimisation thérapeutique en neuropharmacologie OTEN U1144, 75006 Paris, France.; Johnson B; SUNY Upstate, Syracuse, New York, NY, USA.; Kapitány-Fövény M; Nyírő Gyula National Insitute of Psychiatry and Addictology, Nyíregyháza, Hungary; Semmelweis University, Faculty of Health Sciences, Nyíregyháza, Hungary.; Levin FR; Columbia University, Vagelos College of Physicians and Surgeons, New York, USA; New York State Psychiatric Institute, New York, USA.; Luderer M; Goethe University Frankfurt, University Hospital, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Frankfurt, Germany.; Matthys F; Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Dpt of Psychiatry and NEUR Research Group, Center for Neurosciences (C4N), Brussels, Belgium.; Moggi F; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.; Palma-Álvarez RF; Department of Mental Health. Hospital Universitari Vall Hebron, Catalonia, Barcelona, Spain; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Barcelona, Spain.; Ramos-Quiroga JA; Department of Mental Health. Hospital Universitari Vall Hebron, Catalonia, Barcelona, Spain; Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Barcelona, Spain.; Reif A; Goethe University Frankfurt, University Hospital, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Frankfurt, Germany.; van Kernebeek MW; Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Dpt of Psychiatry and NEUR Research Group, Center for Neurosciences (C4N), Brussels, Belgium; PsychoSociaal Centrum Elsene, Brussels, Belgium.; Vélez-Pastrana MC; Universidad Albizu, Ph.D. Program in Clinical Psychology, San Juan, Puerto Rico, USA.; van den Brink W; Amsterdam University Medical Centers, Department of Psychiatry, Amsterdam, the Netherlands.; Franck J; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Sweden.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111390 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7862 (Electronic) Linking ISSN: 0924977X NLM ISO Abbreviation: Eur Neuropsychopharmacol Subsets: MEDLINE

Loftus, J.; Scott, J.; Vorspan, F.; Icick, R.; Henry, C.; Gard, S.; Kahn, J. P.; Leboyer, M.; Bellivier, F.; Etain, B.

Journal of Affective Disorders. 267:258-263

Al-Soufi L; Psychiatric Genetics group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Galicia, Spain. Red de Investigación en Atención Primaria de Adicciones (RIAPAd).; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Galicia, Spain.; Hindley G; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Rødevand L; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Shadrin AA; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Jaholkowski P; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Fominykh V; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Icick R; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Université Paris-Cité, INSERM, Optimisation thérapeutique en neuropsychopharmacologie OPTEN U1144, 75006, Paris, France.; Tesfaye M; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.; Costas J; Psychiatric Genetics group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Galicia, Spain. Red de Investigación en Atención Primaria de Adicciones (RIAPAd).; Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Galicia, Spain.; Andreassen OA; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Publisher: Cambridge University Press Country of Publication: England NLM ID: 1254142 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-8978 (Electronic) Linking ISSN: 00332917 NLM ISO Abbreviation: Psychol Med Subsets: MEDLINE

J. Chabert; R. Icick; J. Cabé; M.-C. Patoz; X. Moisset; O. Godin; S. Gard; J. Loftus; V. Aubin; R. Belzeaux; C. Dubertret; Y. Lestrat; N. Mazer; A. De Premorel; P. Roux; M. Polosan; T. Schwitzer; B. Aouizerate; B. Isabelle; B. Etain; R. Moirand; E. Olié; E. Haffen; M. Leboyer; P. Courtet; P.-M. Llorca; G. Brousse; L. Samalin

European Psychiatry, Vol 66, Pp S199-S200 (2023)

Therribout, N.; van Kernebeek, M.W.; Vorspan, F.; Crunelle, C.L.; van den Brink, W.; Özgen, H.; Spijkerman, R.; Noack, M.; Holtmann, M.; Schellekens, A.S.A.; van de Glind, G.; Hendriks, V.; Dom, G.; Moggi, F.; Konstenius, M.; Franck, J.; Levin, F.R.; Ramos-Quiroga, J.A.; Demetrovics, Z.; Coetzee, C.; Luderer, M.; Matthys, F.; Icick, R.; Romo, L.; null, null; Young, Jesse; Grocott, Dianne; Kaye, Sharlene; Verspreet, Sofie; Dalsgaard, Søren; Karsinti, Emily; Kiefer, Falk; Vollstädt-Klein, Sabine; Kapitány-Fövény, Máté; Barta, Csaba; Rabinovitz, Sharon; Slobodin, Ortal; Skutle, Arvid; Abel, Kristine Fiksdal; Velez-Pastrana, Maria C.; Meyer, Anneke; Truter, Ilse; Regnart, Judith; Casas, Miguel; Grau, Lara; Daigre, Blanco Constanza; Ribasés, Marta; Konstenius, Maija; Brynte, Christoffer; Bäcker, Amanda; Burren, Yuliya; Paraskevopoulou, Maria; Begeman, Alex; Schoevers, Robert; Hartkoorn, Christel; Przezdzik, Izabela; Shafi, Abu; Sala, Regina; Gonzalez, Rafael A.; Faraone, Stephen V.; Johnson, Brian; Yule, Amy

Glastad, S.H.; Busch, C.; Melle, I.; Høegh, M.C.; Klungsøyr, O.; Aminoff, S.R.; Lagerberg, T.V.; Hagen, R.; Bjella, T.; Andreassen, O.A.; Engen, M.J.; Lyngstad, S.H.; Icick, R.; Etain, B.

In: International Journal of Bipolar Disorders. (International Journal of Bipolar Disorders, December 2025, 13(1))

Martino T; APHP, GHU APHP. Nord-Université Paris Cité, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 200 rue du Faubourg Saint-Denis, Paris F-75010, France.; Université Paris Saclay, UFR de Médecine, Département de Médecine Générale, 63 rue Gabriel Péri, Le Kremlin-Bicêtre F-94270, France.; Dereux A; APHP, GHU APHP. Nord-Université Paris Cité, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 200 rue du Faubourg Saint-Denis, Paris F-75010, France.; Université Paris Cité, INSERM, Optimisation thérapeutique en neuropharmacologie OTEN U1144, 4 avenue de l'Observatoire, Paris F-75006, France.; Resalcog - Réseau pour la prise en charge des troubles cognitifs liés à l'alcool, 51bis rue des Epinettes, Paris F-75017, France.; Samson C; APHP, GHU APHP. Nord-Université Paris Cité, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 200 rue du Faubourg Saint-Denis, Paris F-75010, France.; Resalcog - Réseau pour la prise en charge des troubles cognitifs liés à l'alcool, 51bis rue des Epinettes, Paris F-75017, France.; APHP, GHU AP-HP. Hôpitaux Universitaires Paris Seine-Saint-Denis, Site René Muret, Service d'Addictologie, 52 avenue du Dr Schaffner, Sevran F-93270, France.; Icick R; APHP, GHU APHP. Nord-Université Paris Cité, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 200 rue du Faubourg Saint-Denis, Paris F-75010, France.; Université Paris Cité, INSERM, Optimisation thérapeutique en neuropharmacologie OTEN U1144, 4 avenue de l'Observatoire, Paris F-75006, France.; Université Paris Cité, UFR de Médecine, 15 rue de l'Ecole de médecine, Paris F-75006, France.; Rollet D; APHP, GHU APHP. Nord-Université Paris Cité, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 200 rue du Faubourg Saint-Denis, Paris F-75010, France.; Azuar J; APHP, GHU APHP. Nord-Université Paris Cité, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 200 rue du Faubourg Saint-Denis, Paris F-75010, France.; Université Paris Cité, INSERM, Optimisation thérapeutique en neuropharmacologie OTEN U1144, 4 avenue de l'Observatoire, Paris F-75006, France.; Resalcog - Réseau pour la prise en charge des troubles cognitifs liés à l'alcool, 51bis rue des Epinettes, Paris F-75017, France.; Questel F; APHP, GHU APHP. Nord-Université Paris Cité, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 200 rue du Faubourg Saint-Denis, Paris F-75010, France.; Université Paris Cité, INSERM, Optimisation thérapeutique en neuropharmacologie OTEN U1144, 4 avenue de l'Observatoire, Paris F-75006, France.; Resalcog - Réseau pour la prise en charge des troubles cognitifs liés à l'alcool, 51bis rue des Epinettes, Paris F-75017, France.; Vorspan F; APHP, GHU APHP. Nord-Université Paris Cité, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 200 rue du Faubourg Saint-Denis, Paris F-75010, France.; Université Paris Cité, INSERM, Optimisation thérapeutique en neuropharmacologie OTEN U1144, 4 avenue de l'Observatoire, Paris F-75006, France.; APHP, GHU AP-HP. Hôpitaux Universitaires Paris Seine-Saint-Denis, Site René Muret, Service d'Addictologie, 52 avenue du Dr Schaffner, Sevran F-93270, France.; Université Paris Cité, UFR de Médecine, 15 rue de l'Ecole de médecine, Paris F-75006, France.; Clergue-Duval V; APHP, GHU APHP. Nord-Université Paris Cité, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 200 rue du Faubourg Saint-Denis, Paris F-75010, France.; Université Paris Cité, INSERM, Optimisation thérapeutique en neuropharmacologie OTEN U1144, 4 avenue de l'Observatoire, Paris F-75006, France.; Resalcog - Réseau pour la prise en charge des troubles cognitifs liés à l'alcool, 51bis rue des Epinettes, Paris F-75017, France.; Université Paris Cité, UFR de Médecine, 15 rue de l'Ecole de médecine, Paris F-75006, France.

Publisher: Oxford University Press Country of Publication: England NLM ID: 8310684 Publication Model: Print Cited Medium: Internet ISSN: 1464-3502 (Electronic) Linking ISSN: 07350414 NLM ISO Abbreviation: Alcohol Alcohol Subsets: MEDLINE

Icick, R.; Melle, I.; Etain, B.; Ringen, P.A.; Aminoff, S.R.; Leboyer, M.; Aas, M.; Henry, C.; Bjella, T.D.; Andreassen, O.A.; Bellivier, F.; Lagerberg, T.V.

Journal of Affective Disorders. 256:348-357

Begeman AH; Outpatient Treatment Centre Amersfoort, De Hoop GGZ, The Netherlands.; Centre for Research and Innovation in Christian Mental Health Care, Hoevelaken, The Netherlands.; School of Education, Ben-Gurion University of the Negev, Beer-Sheva, South District, Israel.; Schellekens A; Department of Psychiatry, Radboudumc, Donders Centre for Medical Neuroscience, Nijmegen, The Netherlands.; Nijmegen Institute for Scientist Practitioners in Addiction (NISPA), The Netherlands.; van den Brink W; Department of Psychiatry, Amsterdam University Medical Center, The Netherlands.; Barta C; Department of Molecular Biology, Institute of Biochemistry and Molecular Biology, Semmelweis University, Budapest, Hungary.; Brynte C; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Crunelle CL; Vrije Universiteit Brussel (VUB), University Hospital Brussels (UZ Brussel), Belgium.; Department of Psychiatry and NEUR Research Group, Center for Neurosciences (C4N), Brussels, Belgium.; De Fuentes-Merillas L; Novadic-Kentron Addiction Treatment Center, Vught, The Netherlands.; Nijmegen Institute for Scientist Practitioners in Addiction (NISPA), Radboud University, The Netherlands.; Demetrovics Z; College of Education, Psychology and Social Work, Flinders University, Adelaide, SA, Australia.; Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.; Dom G; Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Wilrijk, Belgium.; Franck J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Grau L; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Biomedical Network Research Center on Mental Health (CIBERSAM), Barcelona, Spain.; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Spain.; Hernandez M; Columbia University Irving Medical Center, New York, NY, USA.; New York State Psychiatric Institute, NY, USA.; Icick R; Université Paris Cité, INSERM U1144, France.; GHU APHP, Nord, Assistance Publique - Hôpitaux de Paris, France.; Kapitány-Fövény M; Nyírő Gyula National Institute of Psychiatry and Addictology, Budapest, Hungary.; Semmelweis University, Faculty of Health Sciences, Budapest, Hungary.; Levin FR; New York State Psychiatric Institute, NY, USA.; Columbia University Vagelos School of Physicians and Surgeons, New York, NY, USA.; Luderer M; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University Frankfurt, University Hospital, Germany.; Markus W; Nijmegen Institute for Scientist Practitioners in Addiction (NISPA), The Netherlands.; IrisZorg, Center for Addiction Care and Sheltered Housing, Arnhem, The Netherlands.; Matthys FI; Vrije Universiteit Brussel (VUB), University Hospital Brussels (UZ Brussel), Belgium.; Department of Psychiatry and NEUR Research Group, Center for Neurosciences (C4N), Brussels, Belgium.; Moggi F; University Hospital of Psychiatry and Psychotherapy, University of Bern, Switzerland.; van Kernebeek M; Vrije Universiteit Brussel (VUB), University Hospital Brussels (UZ Brussel), Belgium.; Department of Psychiatry and NEUR Research Group, Center for Neurosciences (C4N), Brussels, Belgium.; Ramos-Quiroga JA; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Spain.; Department of Mental Health, Hospital Univeristari Vall d'Hebron, Barcelona, Spain.; Biomedical Network Research Center on Mental Health (CIBERSAM), Madrid, Spain.; Slobodin O; School of Education, Ben-Gurion University of the Negev, Beer-Sheva, South District, Israel.; Schaap-Jonker H; Centre for Research and Innovation in Christian Mental Health Care, Hoevelaken, The Netherlands.; Faculty of Religion and Theology, Vrije Universiteit Amsterdam, The Netherlands.

Publisher: Sage Publications Country of Publication: England NLM ID: 0374726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1741-2854 (Electronic) Linking ISSN: 00207640 NLM ISO Abbreviation: Int J Soc Psychiatry Subsets: MEDLINE

Thomas D. Bjella; Margrethe Collier Høegh; Stine Holmstul Olsen; Sofie R. Aminoff; Elizabeth Barrett; Torill Ueland; Romain Icick; Ole A. Andreassen; Mari Nerhus; Henrik Myhre Ihler; Marthe Hagen; Cecilie Busch-Christensen; Ingrid Melle; Trine Vik Lagerberg

Frontiers in Medical Technology, Vol 4 (2022)

Romain Icick; Ingrid Melle; Bruno Etain; Margrethe Collier Høegh; Sébastien Gard; Sofie R. Aminoff; Marion Leboyer; Ole A. Andreassen; Raoul Belzeaux; Chantal Henry; Thomas D. Bjella; Jean-Pierre Kahn; Nils Eiel Steen; Frank Bellivier; Trine Vik Lagerberg

Frontiers in Psychiatry, Vol 13 (2022)

Salloum N; Département de Psychiatrie et de Médecine Addictologique, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint-Denis, Paris, 75010, France.; UFR de Médecine, Université Paris Cité, 85 Boulevard Saint-Germain, Paris, 75006, France.; Chouchana M; Service de Pharmacie Hospitalière, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint- Denis, Paris, 75010, France.; UFR de Pharmacie, Université Paris Cité, 85 boulevard Saint-Germain, Paris, 75006, France.; UMRS-1144 Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM, Université Paris Cité, 4 Avenue de l'observatoire, Paris, 75006, France.; FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France.; Icick R; Département de Psychiatrie et de Médecine Addictologique, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint-Denis, Paris, 75010, France.; UFR de Médecine, Université Paris Cité, 85 Boulevard Saint-Germain, Paris, 75006, France.; UMRS-1144 Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM, Université Paris Cité, 4 Avenue de l'observatoire, Paris, 75006, France.; FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France.; Bloch V; Service de Pharmacie Hospitalière, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint- Denis, Paris, 75010, France.; UFR de Pharmacie, Université Paris Cité, 85 boulevard Saint-Germain, Paris, 75006, France.; UMRS-1144 Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM, Université Paris Cité, 4 Avenue de l'observatoire, Paris, 75006, France.; FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France.; Daumas S; FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France.; Neuroscience Paris Seine, Institut de Biologie Paris Seine (NPS- IBPS), INSERM, CNRS, Sorbonne Université, 9 quai Saint Bernard, Paris, 75005, France.; Mestikawy SE; FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France.; Neuroscience Paris Seine, Institut de Biologie Paris Seine (NPS- IBPS), INSERM, CNRS, Sorbonne Université, 9 quai Saint Bernard, Paris, 75005, France.; Départment of Psychiatry, Douglas Research Center, McGill University, 6875 Boulevard Lasalle, Montréal, QC, H4H 1R3, Canada.; Vorspan F; Département de Psychiatrie et de Médecine Addictologique, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint-Denis, Paris, 75010, France.; UFR de Médecine, Université Paris Cité, 85 Boulevard Saint-Germain, Paris, 75006, France.; UMRS-1144 Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM, Université Paris Cité, 4 Avenue de l'observatoire, Paris, 75006, France.; FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France.; Clergue-Duval V; Département de Psychiatrie et de Médecine Addictologique, Site Lariboisière Fernand-Widal, GHU APHP.Nord - Université Paris Cité, 200 Rue du Faubourg Saint-Denis, Paris, 75010, France. virgile.clergue-duval@aphp.fr.; UFR de Médecine, Université Paris Cité, 85 Boulevard Saint-Germain, Paris, 75006, France. virgile.clergue-duval@aphp.fr.; UMRS-1144 Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM, Université Paris Cité, 4 Avenue de l'observatoire, Paris, 75006, France. virgile.clergue-duval@aphp.fr.; FHU Network of Research in Substance Use Disorders (NOR-SUD), 4 Avenue de l'observatoire, Paris, 75006, France. virgile.clergue-duval@aphp.fr.

Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE

Poireau M; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; FHU NOR-SUD (Network of Research in Substance Use Disorders), APHP, Paris, France.; Clergue-Duval V; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; Maillard A; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; Icick R; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; Azuar J; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; Smith P; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; Faurent M; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; Volle E; FRONT-Lab, ICM Institut du Cerveau, INSERM, Paris, France.; Delmaire C; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; Service de Neuroradiologie, Fondation Ophtalmologique Rothschild, Paris, France.; Cabé J; Clermont Auvergne INP, CHU Clermont-Ferrand, CNRS, Institut Pascal, Université Clermont Auvergne, Clermont-Ferrand, France.; Bloch V; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; FHU NOR-SUD (Network of Research in Substance Use Disorders), APHP, Paris, France.; Service de Pharmacie à Usage Interne, Hôpital Fernand Widal, APHP, Paris, France.; Vorspan F; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.; Université Paris Cité, UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, INSERM, Paris, France.; FHU NOR-SUD (Network of Research in Substance Use Disorders), APHP, Paris, France.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0391 (Electronic) Linking ISSN: 10550496 NLM ISO Abbreviation: Am J Addict Subsets: MEDLINE

Icick, R. ; Vorspan, F. ; Karsinti, E. ; Ksouda, K. ; Lépine, J-P. ; Brousse, G. ; Mouly, S. ; Bellivier, F. ; Bloch, V.

In Journal of Affective Disorders 1 December 2018 241:546-553